Search Results - "Richter, Matthias J"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity by Richter, Matthias J., Wagmann, Lea, Gampfer, Tanja M., Brandt, Simon D., Meyer, Markus R.

    Published in Metabolites (03-08-2021)
    “…Quinolin-8-yl 4-methyl-3-(piperidine-1-sulfonyl)benzoate (QMPSB) and quinolin-8-yl 4-methyl-3-(piperidine-1-carbonyl)benzoate (QMPCB, SGT-11) are synthetic…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam by Wagmann, Lea, Manier, Sascha K, Felske, Christina, Gampfer, Tanja M, Richter, Matthias J, Eckstein, Niels, Meyer, Markus R

    Published in Journal of analytical toxicology (09-11-2021)
    “…Abstract Flubromazolam is widely known as highly potent designer benzodiazepine (DBZD). Recently, the two flubromazolam-derived new psychoactive substances…”
    Get full text
    Journal Article
  4. 4

    Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl by Gampfer, Tanja M, Wagmann, Lea, Richter, Matthias J, Fischmann, Svenja, Westphal, Folker, Meyer, Markus R

    Published in Journal of analytical toxicology (02-04-2020)
    “…Abstract The growing number of new synthetic opioids (NSO) on the new psychoactive substances (NPS) market bears new challenges in toxicology. As their…”
    Get full text
    Journal Article
  5. 5
  6. 6